Thank you for visiting the mAb 麻豆传媒高清 Website!
On this website you will find the archive of products and research findings from the mAb 麻豆传媒高清 project. However, as of May 2022 only the "Research" tab will be updated. Please contact your healthcare provider if you are trying to find monoclonal antibody treatment for COVID-19.
COVID-19 monoclonal antibodies (mAb) are a treatment for people who have COVID-19.
Contact your healthcare provider if you are trying to find mAb treatment for COVID-19.
To learn more about monoclonal antibodies for COVID-19 visit Combat Covid maintained by US Health and Human Services.
This guide aims to provide practical guidance to help clinicians and other key stakeholders increase awareness and access to COVID-19 mAbs for outpatients with mild to moderate SARS-CoV-2 infection.
In different modules, we provide resources and examples of clinical workflows to increase:
This implementation blueprint, including its component patient and clinician handouts, were developed between June 2021-December 2021. Information provided reflects information gathered prior to the rapid spread of the Omicron variant of the SARS-CoV-2 virus. This implementation blueprint is provided for reference if/when other mAb treatments are again shown to be effective.
Click here to view the mAb Implementation Blueprint for COVID-19 which includes modules for referral to mAb treatment sites, intravenous treatment, subcutaneous treatment, and local public health processes.
The mAb graphic novel walks viewers through the process of getting monoclonal antibodies (mAb) for COVID-19 and covers:
All in a brief and easy-to-understand 2-minute animated video.
For more information on how you can get treated with monoclonal antibodies please visit the CDPHE treatment webpage.
This project was funded by a grant from the National Institutes of Health (NIH) and National Center for Advancing Translational Sciences (NCATS) (award number UL1-TR002535-03S3).